Clinical Trials Directory

Trials / Completed

CompletedNCT00106652

Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)

Environmental Factors in the Etiology of Autism

Status
Completed
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
National Institute of Environmental Health Sciences (NIEHS) · NIH
Sex
All
Age
24 Months – 60 Months
Healthy volunteers
Accepted

Summary

The purpose of this study is to understand how genes, environment, and the interplay between the two, influences the development of autism and other neurodevelopmental disorders.

Detailed description

The causes and contributing factors for autism are poorly understood. Evidence suggests that incidence is increasing, but diagnostic changes and improvements may be playing a role. Both genetic and environmental factors appear to play a role. Autopsy studies demonstrate structural changes in the brain and clinical investigations reveal neurophysiologic differences in information processing in autistic versus normal children. Members of our team recently demonstrated altered levels of certain neuropeptides at birth in children who later developed autism. This case-control study is the first large-scale epidemiologic investigation of underlying causes for autism and triggers of regression. This study capitalizes on the strengths of the case-control design, which is well suited to examine a broad array of factors for rare conditions that are thought to be multifactorial. Comparisons will be made with both general population controls and mentally retarded children. The aims are to assess the influence of exogenous exposures, the role of susceptibility factors, and the interplay between these two in the etiology of autism and its phenotypic variation. Chemicals with known or suspected neurodevelopmental toxicity, such as PCB's, certain pesticides, and metals, are being investigated. This study pursues several hypotheses that have recently gained attention, including the combined measles, mumps, rubella vaccine and mercury present in vaccines given during infancy and early childhood. Additionally, biochemical susceptibility is examined through characterization of metabolic, immunologic, and neuronal gene expression profiles and genetic polymorphisms.

Conditions

Timeline

Start date
2001-09-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2005-03-29
Last updated
2017-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00106652. Inclusion in this directory is not an endorsement.